Evan Jones's most recent trade in Veracyte Inc was a trade of 9,321 Common Stock done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Veracyte Inc | Evan Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 9,321 | 43,664 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 35.23 per share. | 19 Sep 2024 | 5,173 | 0 (0%) | 0% | 35.2 | 182,263 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 32.36 per share. | 12 Aug 2024 | 22,407 | 6,085 (0%) | 0% | 32.4 | 725,026 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 32.36 per share. | 12 Aug 2024 | 16,838 | 35,031 (0%) | 0% | 32.4 | 544,851 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2024 | 8,486 | 0 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Evan Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.41 per share. | 12 Aug 2024 | 8,486 | 54,800 (0%) | 0% | 10.4 | 88,339 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 31.19 per share. | 12 Aug 2024 | 3,869 | 28,492 (0%) | 0% | 31.2 | 120,655 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 31.19 per share. | 12 Aug 2024 | 2,931 | 51,869 (0%) | 0% | 31.2 | 91,406 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 32.77 per share. | 12 Aug 2024 | 912 | 5,173 (0%) | 0% | 32.8 | 29,884 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 32.77 per share. | 12 Aug 2024 | 688 | 34,343 (0%) | 0% | 32.8 | 22,544 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.01 per share. | 12 Aug 2024 | 101 | 32,361 (0%) | 0% | 30.0 | 3,031 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.01 per share. | 12 Aug 2024 | 99 | 46,314 (0%) | 0% | 30.0 | 2,971 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.03 per share. | 09 Aug 2024 | 1,032 | 46,413 (0%) | 0% | 30.0 | 30,990 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.03 per share. | 09 Aug 2024 | 746 | 32,462 (0%) | 0% | 30.0 | 22,402 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.41 per share. | 09 Aug 2024 | 300 | 47,445 (0%) | 0% | 10.4 | 3,123 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2024 | 300 | 8,486 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.32 per share. | 07 Aug 2024 | 5,108 | 45,180 (0%) | 0% | 30.3 | 154,883 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.32 per share. | 07 Aug 2024 | 3,143 | 47,145 (0%) | 0% | 30.3 | 95,301 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.32 per share. | 07 Aug 2024 | 1,965 | 33,208 (0%) | 0% | 30.3 | 59,582 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2024 | 1,214 | 8,786 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Evan Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.41 per share. | 07 Aug 2024 | 1,214 | 50,288 (0%) | 0% | 10.4 | 12,638 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,473 | 49,074 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Evan Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 24.36 per share. | 01 Mar 2024 | 10,000 | 37,601 (0%) | 0% | 24.4 | 243,599 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.19 per share. | 01 Mar 2024 | 10,000 | 47,601 (0%) | 0% | 13.2 | 131,900 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.17 per share. | 19 Jul 2023 | 3,090 | 35,173 (0%) | 0% | 30.2 | 93,232 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.14 per share. | 19 Jul 2023 | 838 | 37,601 (0%) | 0% | 30.1 | 25,257 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.07 per share. | 17 Jul 2023 | 23,949 | 45,704 (0%) | 0% | 30.1 | 720,106 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.07 per share. | 17 Jul 2023 | 19,095 | 40,763 (0%) | 0% | 30.1 | 574,106 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.19 per share. | 17 Jul 2023 | 7,441 | 38,263 (0%) | 0% | 30.2 | 224,616 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.16 per share. | 17 Jul 2023 | 2,324 | 38,439 (0%) | 0% | 30.2 | 70,090 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 9,674 | 59,858 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.51 per share. | 13 Dec 2022 | 1,367 | 51,084 (0%) | 0% | 30.5 | 41,703 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 31.65 per share. | 13 Dec 2022 | 300 | 50,784 (0%) | 0% | 31.6 | 9,494 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 30.21 per share. | 11 Nov 2022 | 5,900 | 52,551 (0%) | 0% | 30.2 | 178,255 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 31.02 per share. | 11 Nov 2022 | 100 | 52,451 (0%) | 0% | 31.0 | 3,102 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 14,731 | 58,451 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Evan Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2022 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Evan Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. | 11 Jan 2022 | 5,000 | 43,720 (0%) | 0% | 4 | 20,000 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 8,720 | 38,720 (0%) | 0% | 0 | Common Stock | |
| Opgen Inc | Evan Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2021 | 883 | 884 | - | - | Restricted Stock Units | |
| Opgen Inc | Evan Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2021 | 883 | 22,617 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Evan Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2021 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Evan Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.36 per share. | 22 Jan 2021 | 5,000 | 30,000 (0%) | 0% | 2.4 | 11,800 | Common Stock |
| Opgen Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 27 Oct 2020 | 1,748 | 21,734 (0%) | 0% | 2.4 | 4,108 | Common Stock |
| Opgen Inc | Evan Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 50,000 | 50,000 | - | - | Stock Option Award | |
| Opgen Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 2.19 per share. | 04 Sep 2020 | 3,612 | 23,482 (0%) | 0% | 2.2 | 7,910 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 35.13 per share. | 31 Jul 2020 | 18,800 | 70,853 (0%) | 0% | 35.1 | 660,403 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 35.56 per share. | 31 Jul 2020 | 16,480 | 93,173 (0%) | 0% | 35.6 | 586,026 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 36.16 per share. | 31 Jul 2020 | 3,520 | 89,653 (0%) | 0% | 36.2 | 127,280 | Common Stock |
| Veracyte Inc | Evan Jones | Director | Sale of securities on an exchange or to another person at price $ 35.60 per share. | 31 Jul 2020 | 1,200 | 69,653 (0%) | 0% | 35.6 | 42,714 | Common Stock |